APO Research
Talk to an analyst

APO RESEARCH · REPORT

Histone Deacetylase 8

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Histone Deacetylase 8 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025186 pages

Choose your research edition.

Industry ResearchHistone Deacetylase 8 Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Histone Deacetylase 8 Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Histone Deacetylase 8 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Histone Deacetylase 8 Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Histone Deacetylase 8 Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Histone Deacetylase 8 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Histone Deacetylase 8 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Histone Deacetylase 8 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Histone Deacetylase 8 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Histone Deacetylase 8 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Histone Deacetylase 8 include Zhejiang Hisun Pharmaceutical Co Ltd, Sigma-Tau SpA, NatureWise Biotech & Medicals Corp, HitGen LTD and Chipscreen Biosciences Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Histone Deacetylase 8 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Histone Deacetylase 8 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Histone Deacetylase 8 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Histone Deacetylase 8 market size, projected growth trends, production technologies, key applications, and end-use industries.

Histone Deacetylase 8 Segment by Company

Zhejiang Hisun Pharmaceutical Co Ltd

Sigma-Tau SpA

NatureWise Biotech & Medicals Corp

HitGen LTD

Chipscreen Biosciences Ltd

Histone Deacetylase 8 Segment by Type

HG-3001

NBM-01

Largazole

Others

Histone Deacetylase 8 Segment by Application

Follicular Lymaphoma

Liver Fibross

Lung Cancer

Others

Histone Deacetylase 8 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Histone Deacetylase 8 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Histone Deacetylase 8 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Histone Deacetylase 8.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Histone Deacetylase 8 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Histone Deacetylase 8 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Histone Deacetylase 8 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Histone Deacetylase 8 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Histone Deacetylase 8 Industry Trends Table 2. Histone Deacetylase 8 Industry Drivers Table 3. Histone Deacetylase 8 Industry Opportunities and Challenges Table 4. Histone Deacetylase 8 Industry Restraints Table 5. Global Histone Deacetylase 8 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Histone Deacetylase 8 Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Histone Deacetylase 8 Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Histone Deacetylase 8 Sales Market Share by Manufacturers Table 9. Global Histone Deacetylase 8 Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Histone Deacetylase 8 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Histone Deacetylase 8 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Histone Deacetylase 8 Manufacturers, Product Type & Application Table 13. Global Histone Deacetylase 8 Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Histone Deacetylase 8 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of HG-3001 Table 17. Major Manufacturers of NBM-01 Table 18. Major Manufacturers of Largazole Table 19. Major Manufacturers of Others Table 20. Global Histone Deacetylase 8 Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Histone Deacetylase 8 Sales by Type (2021-2026) & (k units) Table 22. Global Histone Deacetylase 8 Sales by Type (2027-2032) & (k units) Table 23. Global Histone Deacetylase 8 Sales Market Share by Type (2021-2026) Table 24. Global Histone Deacetylase 8 Sales Market Share by Type (2027-2032) Table 25. Global Histone Deacetylase 8 Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Histone Deacetylase 8 Revenue by Type (2021-2026) & (k units) Table 27. Global Histone Deacetylase 8 Revenue by Type (2027-2032) & (k units) Table 28. Global Histone Deacetylase 8 Revenue Market Share by Type (2021-2026) Table 29. Global Histone Deacetylase 8 Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Follicular Lymaphoma Table 31. Major Manufacturers of Liver Fibross Table 32. Major Manufacturers of Lung Cancer Table 33. Major Manufacturers of Others Table 34. Global Histone Deacetylase 8 Sales by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Histone Deacetylase 8 Sales by Application (2021-2026) & (k units) Table 36. Global Histone Deacetylase 8 Sales by Application (2027-2032) & (k units) Table 37. Global Histone Deacetylase 8 Sales Market Share by Application (2021-2026) Table 38. Global Histone Deacetylase 8 Sales Market Share by Application (2027-2032) Table 39. Global Histone Deacetylase 8 Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 40. Global Histone Deacetylase 8 Revenue by Application (2021-2026) & (k units) Table 41. Global Histone Deacetylase 8 Revenue by Application (2027-2032) & (k units) Table 42. Global Histone Deacetylase 8 Revenue Market Share by Application (2021-2026) Table 43. Global Histone Deacetylase 8 Revenue Market Share by Application (2027-2032) Table 44. Global Histone Deacetylase 8 Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Histone Deacetylase 8 Sales by Region (2021-2026) & (k units) Table 46. Global Histone Deacetylase 8 Sales Market Share by Region (2021-2026) Table 47. Global Histone Deacetylase 8 Sales Forecasted by Region (2027-2032) & (k units) Table 48. Global Histone Deacetylase 8 Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Histone Deacetylase 8 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. North America Histone Deacetylase 8 Sales by Country (2021-2026) & (k units) Table 51. North America Histone Deacetylase 8 Sales by Country (2027-2032) & (k units) Table 52. Europe Histone Deacetylase 8 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Europe Histone Deacetylase 8 Sales by Country (2021-2026) & (k units) Table 54. Europe Histone Deacetylase 8 Sales by Country (2027-2032) & (k units) Table 55. Asia Pacific Histone Deacetylase 8 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Asia Pacific Histone Deacetylase 8 Sales by Country (2021-2026) & (k units) Table 57. Asia Pacific Histone Deacetylase 8 Sales by Country (2027-2032) & (k units) Table 58. South America, Middle East and Africa Histone Deacetylase 8 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 59. South America, Middle East and Africa Histone Deacetylase 8 Sales by Country (2021-2026) & (k units) Table 60. South America, Middle East and Africa Histone Deacetylase 8 Sales by Country (2027-2032) & (k units) Table 61. Global Histone Deacetylase 8 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Histone Deacetylase 8 Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Histone Deacetylase 8 Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Histone Deacetylase 8 Revenue Market Share by Region (2021-2026) Table 65. Global Histone Deacetylase 8 Revenue Market Share by Region (2027-2032) Table 66. Zhejiang Hisun Pharmaceutical Co Ltd Company Information Table 67. Zhejiang Hisun Pharmaceutical Co Ltd Business Overview Table 68. Zhejiang Hisun Pharmaceutical Co Ltd Histone Deacetylase 8 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Zhejiang Hisun Pharmaceutical Co Ltd Histone Deacetylase 8 Product Portfolio Table 70. Zhejiang Hisun Pharmaceutical Co Ltd Recent Development Table 71. Sigma-Tau SpA Company Information Table 72. Sigma-Tau SpA Business Overview Table 73. Sigma-Tau SpA Histone Deacetylase 8 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Sigma-Tau SpA Histone Deacetylase 8 Product Portfolio Table 75. Sigma-Tau SpA Recent Development Table 76. NatureWise Biotech & Medicals Corp Company Information Table 77. NatureWise Biotech & Medicals Corp Business Overview Table 78. NatureWise Biotech & Medicals Corp Histone Deacetylase 8 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. NatureWise Biotech & Medicals Corp Histone Deacetylase 8 Product Portfolio Table 80. NatureWise Biotech & Medicals Corp Recent Development Table 81. HitGen LTD Company Information Table 82. HitGen LTD Business Overview Table 83. HitGen LTD Histone Deacetylase 8 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. HitGen LTD Histone Deacetylase 8 Product Portfolio Table 85. HitGen LTD Recent Development Table 86. Chipscreen Biosciences Ltd Company Information Table 87. Chipscreen Biosciences Ltd Business Overview Table 88. Chipscreen Biosciences Ltd Histone Deacetylase 8 Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Chipscreen Biosciences Ltd Histone Deacetylase 8 Product Portfolio Table 90. Chipscreen Biosciences Ltd Recent Development Table 91. Key Raw Materials Table 92. Raw Materials Key Suppliers Table 93. Histone Deacetylase 8 Distributors List Table 94. Histone Deacetylase 8 Customers List Table 95. Research Programs/Design for This Report Table 96. Authors List of This Report Table 97. Secondary Sources Table 98. Primary Sources List of Figures Figure 1. Histone Deacetylase 8 Product Image Figure 2. Global Histone Deacetylase 8 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Histone Deacetylase 8 Market Size (2021-2032) & (US$ Million) Figure 4. Global Histone Deacetylase 8 Sales (2021-2032) & (k units) Figure 5. Global Histone Deacetylase 8 Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Histone Deacetylase 8 Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. HG-3001 Image Figure 9. NBM-01 Image Figure 10. Largazole Image Figure 11. Others Image Figure 12. Global Histone Deacetylase 8 Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Histone Deacetylase 8 Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Histone Deacetylase 8 Sales Market Share by Type (2021-2032) Figure 15. Global Histone Deacetylase 8 Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Histone Deacetylase 8 Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Histone Deacetylase 8 Revenue Market Share by Type (2021-2032) Figure 18. Follicular Lymaphoma Image Figure 19. Liver Fibross Image Figure 20. Lung Cancer Image Figure 21. Others Image Figure 22. Global Histone Deacetylase 8 Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Histone Deacetylase 8 Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Histone Deacetylase 8 Sales Market Share by Application (2021-2032) Figure 25. Global Histone Deacetylase 8 Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Histone Deacetylase 8 Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Histone Deacetylase 8 Revenue Market Share by Application (2021-2032) Figure 28. North America Histone Deacetylase 8 Sales and Growth Rate (2021-2032) & (k units) Figure 29. North America Histone Deacetylase 8 Sales Market Share by Country (2021-2032) Figure 30. U.S. Histone Deacetylase 8 Sales and Growth Rate (2021-2032) & (k units) Figure 31. Canada Histone Deacetylase 8 Sales and Growth Rate (2021-2032) & (k units) Figure 32. Mexico Histone Deacetylase 8 Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Histone Deacetylase 8 Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Histone Deacetylase 8 Sales Market Share by Country (2021-2032) Figure 35. Germany Histone Deacetylase 8 Sales and Growth Rate (2021-2032) & (k units) Figure 36. France Histone Deacetylase 8 Sales and Growth Rate (2021-2032) & (k units) Figure 37. U.K. Histone Deacetylase 8 Sales and Growth Rate (2021-2032) & (k units) Figure 38. Italy Histone Deacetylase 8 Sales and Growth Rate (2021-2032) & (k units) Figure 39. Netherlands Histone Deacetylase 8 Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Histone Deacetylase 8 Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Histone Deacetylase 8 Sales Market Share by Country (2021-2032) Figure 42. China Histone Deacetylase 8 Sales and Growth Rate (2021-2032) & (k units) Figure 43. Japan Histone Deacetylase 8 Sales and Growth Rate (2021-2032) & (k units) Figure 44. South Korea Histone Deacetylase 8 Sales and Growth Rate (2021-2032) & (k units) Figure 45. Southeast Asia Histone Deacetylase 8 Sales and Growth Rate (2021-2032) & (k units) Figure 46. India Histone Deacetylase 8 Sales and Growth Rate (2021-2032) & (k units) Figure 47. Australia Histone Deacetylase 8 Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Histone Deacetylase 8 Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Histone Deacetylase 8 Sales Market Share by Country (2021-2032) Figure 50. Brazil Histone Deacetylase 8 Sales and Growth Rate (2021-2032) & (k units) Figure 51. South Africa Histone Deacetylase 8 Sales and Growth Rate (2021-2032) & (k units) Figure 52. Saudi Arabia Histone Deacetylase 8 Sales and Growth Rate (2021-2032) & (k units) Figure 53. Turkey Histone Deacetylase 8 Sales and Growth Rate (2021-2032) & (k units) Figure 54. Argentina Histone Deacetylase 8 Sales and Growth Rate (2021-2032) & (k units) Figure 55. UAE Histone Deacetylase 8 Sales and Growth Rate (2021-2032) & (k units) Figure 56. Egypt Histone Deacetylase 8 Sales and Growth Rate (2021-2032) & (k units) Figure 57. Chile Histone Deacetylase 8 Sales and Growth Rate (2021-2032) & (k units) Figure 58. Global Histone Deacetylase 8 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Histone Deacetylase 8 Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Histone Deacetylase 8 Revenue (2021-2032) & (US$ Million) Figure 61. North America Histone Deacetylase 8 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Histone Deacetylase 8 Revenue (2021-2032) & (US$ Million) Figure 63. Europe Histone Deacetylase 8 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Histone Deacetylase 8 Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Histone Deacetylase 8 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Histone Deacetylase 8 Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Histone Deacetylase 8 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Histone Deacetylase 8 Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Histone Deacetylase 8 Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • HG-3001
  • NBM-01
  • Largazole
  • Others
Applications
  • Follicular Lymaphoma
  • Liver Fibross
  • Lung Cancer
  • Others
Companies covered
  • Zhejiang Hisun Pharmaceutical Co Ltd
  • Sigma-Tau SpA
  • NatureWise Biotech & Medicals Corp
  • HitGen LTD
  • Chipscreen Biosciences Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Histone Deacetylase 8 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Histone Deacetylase 8 Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Histone Deacetylase 8 Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Histone Deacetylase 8 Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Histone Deacetylase 8 Market Dynamics
  1. 2.1 Histone Deacetylase 8 Industry Trends
  2. 2.2 Histone Deacetylase 8 Industry Drivers
  3. 2.3 Histone Deacetylase 8 Industry Opportunities and Challenges
  4. 2.4 Histone Deacetylase 8 Industry Restraints
3 Histone Deacetylase 8 Market by Manufacturers
  1. 3.1 Global Histone Deacetylase 8 Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Histone Deacetylase 8 Sales by Manufacturers (2021-2026)
  3. 3.3 Global Histone Deacetylase 8 Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Histone Deacetylase 8 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Histone Deacetylase 8 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Histone Deacetylase 8 Manufacturers, Product Type & Application
  7. 3.7 Global Histone Deacetylase 8 Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Histone Deacetylase 8 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Histone Deacetylase 8 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Histone Deacetylase 8 Tier 1, Tier 2, and Tier 3
4 Histone Deacetylase 8 Market by Type
  1. 4.1 Histone Deacetylase 8 Type Introduction
  2. 4.1.1 HG-3001
  3. 4.1.2 NBM-01
  4. 4.1.3 Largazole
  5. 4.1.4 Others
  6. 4.2 Global Histone Deacetylase 8 Sales by Type
  7. 4.2.1 Global Histone Deacetylase 8 Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Histone Deacetylase 8 Sales by Type (2021-2032)
  9. 4.2.3 Global Histone Deacetylase 8 Sales Market Share by Type (2021-2032)
  10. 4.3 Global Histone Deacetylase 8 Revenue by Type
  11. 4.3.1 Global Histone Deacetylase 8 Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Histone Deacetylase 8 Revenue by Type (2021-2032)
  13. 4.3.3 Global Histone Deacetylase 8 Revenue Market Share by Type (2021-2032)
5 Histone Deacetylase 8 Market by Application
  1. 5.1 Histone Deacetylase 8 Application Introduction
  2. 5.1.1 Follicular Lymaphoma
  3. 5.1.2 Liver Fibross
  4. 5.1.3 Lung Cancer
  5. 5.1.4 Others
  6. 5.2 Global Histone Deacetylase 8 Sales by Application
  7. 5.2.1 Global Histone Deacetylase 8 Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Histone Deacetylase 8 Sales by Application (2021-2032)
  9. 5.2.3 Global Histone Deacetylase 8 Sales Market Share by Application (2021-2032)
  10. 5.3 Global Histone Deacetylase 8 Revenue by Application
  11. 5.3.1 Global Histone Deacetylase 8 Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Histone Deacetylase 8 Revenue by Application (2021-2032)
  13. 5.3.3 Global Histone Deacetylase 8 Revenue Market Share by Application (2021-2032)
6 Global Histone Deacetylase 8 Sales by Region
  1. 6.1 Global Histone Deacetylase 8 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Histone Deacetylase 8 Sales by Region (2021-2032)
  3. 6.2.1 Global Histone Deacetylase 8 Sales by Region (2021-2026)
  4. 6.2.2 Global Histone Deacetylase 8 Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Histone Deacetylase 8 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Histone Deacetylase 8 Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Histone Deacetylase 8 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Histone Deacetylase 8 Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Histone Deacetylase 8 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Histone Deacetylase 8 Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Histone Deacetylase 8 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Histone Deacetylase 8 Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Histone Deacetylase 8 Revenue by Region
  1. 7.1 Global Histone Deacetylase 8 Revenue by Region
  2. 7.1.1 Global Histone Deacetylase 8 Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Histone Deacetylase 8 Revenue by Region (2021-2026)
  4. 7.1.3 Global Histone Deacetylase 8 Revenue by Region (2027-2032)
  5. 7.1.4 Global Histone Deacetylase 8 Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Histone Deacetylase 8 Revenue (2021-2032)
  8. 7.2.2 North America Histone Deacetylase 8 Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Histone Deacetylase 8 Revenue (2021-2032)
  11. 7.3.2 Europe Histone Deacetylase 8 Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Histone Deacetylase 8 Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Histone Deacetylase 8 Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Histone Deacetylase 8 Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Histone Deacetylase 8 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Hisun Pharmaceutical Co Ltd
  2. 8.1.1 Zhejiang Hisun Pharmaceutical Co Ltd Company Information
  3. 8.1.2 Zhejiang Hisun Pharmaceutical Co Ltd Business Overview
  4. 8.1.3 Zhejiang Hisun Pharmaceutical Co Ltd Histone Deacetylase 8 Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Hisun Pharmaceutical Co Ltd Histone Deacetylase 8 Product Portfolio
  6. 8.1.5 Zhejiang Hisun Pharmaceutical Co Ltd Recent Developments
  7. 8.2 Sigma-Tau SpA
  8. 8.2.1 Sigma-Tau SpA Company Information
  9. 8.2.2 Sigma-Tau SpA Business Overview
  10. 8.2.3 Sigma-Tau SpA Histone Deacetylase 8 Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sigma-Tau SpA Histone Deacetylase 8 Product Portfolio
  12. 8.2.5 Sigma-Tau SpA Recent Developments
  13. 8.3 NatureWise Biotech & Medicals Corp
  14. 8.3.1 NatureWise Biotech & Medicals Corp Company Information
  15. 8.3.2 NatureWise Biotech & Medicals Corp Business Overview
  16. 8.3.3 NatureWise Biotech & Medicals Corp Histone Deacetylase 8 Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 NatureWise Biotech & Medicals Corp Histone Deacetylase 8 Product Portfolio
  18. 8.3.5 NatureWise Biotech & Medicals Corp Recent Developments
  19. 8.4 HitGen LTD
  20. 8.4.1 HitGen LTD Company Information
  21. 8.4.2 HitGen LTD Business Overview
  22. 8.4.3 HitGen LTD Histone Deacetylase 8 Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 HitGen LTD Histone Deacetylase 8 Product Portfolio
  24. 8.4.5 HitGen LTD Recent Developments
  25. 8.5 Chipscreen Biosciences Ltd
  26. 8.5.1 Chipscreen Biosciences Ltd Company Information
  27. 8.5.2 Chipscreen Biosciences Ltd Business Overview
  28. 8.5.3 Chipscreen Biosciences Ltd Histone Deacetylase 8 Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Chipscreen Biosciences Ltd Histone Deacetylase 8 Product Portfolio
  30. 8.5.5 Chipscreen Biosciences Ltd Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Histone Deacetylase 8 Value Chain Analysis
  2. 9.1.1 Histone Deacetylase 8 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Histone Deacetylase 8 Production Mode & Process
  6. 9.2 Histone Deacetylase 8 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Histone Deacetylase 8 Distributors
  9. 9.2.3 Histone Deacetylase 8 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst